Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma. Maesaka K, Sakamori R, Yamada R, Tahata Y, et al. Anticancer Res 2021;41:2187-2192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maesaka K, Sakamori R, Yamada R, Tahata Y, et al. Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma. Anticancer Res 2021;41:2187-2192.
PMID: 33813432